Mesothelioma is a deadly disease which is not restricted to any one person or one nation. It is caused due to asbestos exposure owing to the mining and manufacture of products with asbestos in nations around the world. This is slowly leading to make mesothelioma becoming a world-wide epidemic.
There is a lot of research being conducted in the field of mesothelioma treatment. Researches help in developing new treatment options or improving the existing traditional treatment options. There are also many mesothelioma clinical trials under way to find out new treatments for ensuring safety and efficiency. However, there is no 100% surety that a particular treatment option for mesothelioma is successful.
Mesothelioma is a rare form of cancer and there are four types of this cancer. Each type is named after the particular part of the body it affects. Mesothelioma occurs in thin membrane that lines the internal organs of the human body including Lungs, Heart or Abdomen.
Ten percent of those diagnosed with Mesothelioma cancer have a prognosis of five years. Reports from Mesothelioma doctors show that the average prognosis for Mesothelioma cancer patients is four months to one year and a half. Because of the rareness of Mesothelioma cancer, it is difficult to produce exact numbers on prognosis. However, the prognoses for Mesothelioma cancer victims are better when it is found in its early stages.
Effusion is the escape of fluid from a vessel into a body cavity. In some cases, mesothelioma sufferers may have certain types of effusion due to their exposure to asbestos fibers, pleural effusion being one of the more common types of effusion.